Long term use of a left ventricular assist device (LVAD) by patients with heart failure may induce regeneration of heart muscle by preventing oxidative damage to a cell-regulator mechanism, according to investigators at UT Southwestern Medical Center.
Heart failure is a debilitating disease in which the hear cannot pump blood efficiently and hence cannot provide sufficient oxygen to organs throughout the body. LVADs are mechanical pumps that substitute for the damaged heart by pumping blood throughout the body, and are sometimes implanted in patients who are awaiting heart transplants. During the study, researchers found that putting in a mechanical pump rests the heart and apparently sends a signal to make new heart cells.
Researchers looked at pre- and post-LVAD samples of heart muscle in 10 patients with heart failure. They examined the paired tissue samples for markers of DNA damage and cell proliferation. Senior author of the study, Dr. Hesham Sadek, said, "We looked at markers of what is called the DNA damage response in cardiomyocytes (heart-muscle cells) of these patients. The response is composed of a cascade of proteins that is activated in response to DNA damage and in turn shuts off the ability of cardiomyocytes to divide. We found that patients who were on LVAD for more than six months had significantly decreased levels of DNA damage response."
The findings raise the prospect of reawakening otherwise quiescent cardiac muscle cells, coaxing them into regenerating new and healthy cells. This study will be an important first step toward uncovering methods of promoting myocardial recovery.
This paper is published online in the Journal of the American College of Cardiology.